Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer

Project Information

RESPONSIFY

Grant agreement ID: 278659

Project closed

Start date 1 February 2012

End date 31 January 2015

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 782 794,13

EU contribution € 5 990 194,60

Coordinated by

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Germany